ClinicalTrials.gg
RecruitingNCT07186933Updated Feb 11, 2026

Driving Pressure During Surgeries With High Risk for Postoperative Pulmonary Complications

An interventional study of PEEP titration for Minimum Driving Pressure and Lung Protective Ventilation in Postoperative Pulmonary Atelectasis, Postoperative Pulmonary Complications and Postoperative Respiratory Failure, sponsored by University General Hospital of Patras. Recruiting at 1 site in Greece. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-02-11.

Sponsored by University General Hospital of Patras · Not applicable, Interventional, and Prevention

From the registry’s dates

  • Started Nov 2025; still recruiting 1 year later.
Phase
Not applicable
Study type
Interventional
Enrollment
200
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The goal of this clinical trial is to compare two different types of perioperative mechanical ventilation (MV), specifically Protective Mechanical Ventilation (PMV) and MV with the lowest possible Driving Pressure (ΔP), in relation to the appearance of postoperative pulmonary complications (PPCs) in adult patients who are operated and have higher risk of PPCs.

The main questions it aims to answer are:

  • Is MV with lower ΔP better than conventional PMV in preventing PPCs in patients with higher risk for PPCs?
  • Does MV with lower ΔP decrease hospital stay, Intensive Care Unit (ICU) need and mortality?
  • Does MV with lower ΔP suit better than PMV to lung characteristics and needs intraoperatively?

Researchers will compare MV with the lowest possible Driving Pressure (ΔP) to Protective Mechanical Ventilation (PMV) to see if any of this is more protective than the other concerning PPCs.

All participants will receive perioperative MV.

Half of them will receive conventional Protective Mechanical Ventilation (PMV). This will include well known generally protective settings for mechanical ventilation of patients, concerning volumes, pressures, respiratory rate, inspiratory gases and ventilation maneuvers.

The rest of participants will be ventilated with the lowest possible Driving Pressure (ΔP). This will be similar to PMV in the chosen volumes, respiratory rate, inspiratory gases and ventilation maneuvers. However, the pressure inside lung at the end of expiration, eg Positive End Expiratory Pressure (PEEP), will be not be preset for every patient. Initially, the investigators will perform a maneuver that will quantify each individual's lung characteristics and mechanics. According to this, the investigators will find the exact PEEP that seems to suit each patients lungs most, and use this perioperatively, trying to provide lungs the best conditions every time.

After the completion of the operation, all the patients will be screened for PPCs, via arterial blood testing and chest X ray, and the results will be statistically analyzed trying to find if any of the forementioned strategies of mechanical ventilation surpasses the other concerning PPCs appearance. PPCs include atelectasis, respiratory failure, bronchospasm, pleural effusion, pneumonia, aspiration and pneumothorax.

Furthermore hospital stay, ICU need and mortality will be noted. Finally, measurements of perioperative lung pressures, volumes and derived variables will be noted and compared statistically as well.

02

Conditions studied

  • Postoperative Pulmonary Atelectasis
  • Postoperative Pulmonary Complications
  • Postoperative Respiratory Failure
  • Postoperative Bronchospasm
  • Postoperative Pleural Effusion
  • Postoperative Pneumothorax
  • Postoperative Pneumonia
  • Postoperative Aspiration Pneumonitis
  • Mechanical Power
  • Driving Pressure

Browse trials for

Keywords

  • Driving Pressure
  • Mechanical Power
  • Atelectasis
  • Pulmonary Complications
  • Postoperative Pulmonary Complications
  • Postoperative Respiratory Failure
  • Elastic Power
03

In context

Pulmonary Atelectasis

377 studies on the registry are indexed under Pulmonary Atelectasis; 93 are open to participants now.

This study's planned enrollment of 200 is above the median of 60 across 268 interventional studies indexed under Pulmonary Atelectasis.

Browse Pulmonary Atelectasis studies →

Lead sponsor

University General Hospital of Patras is the lead sponsor of 4 studies on the registry; 3 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • >17 years old
  • Surgery with general anesthesia \& invasive mechanical ventilation
  • Preoperative ARISCAT score estimation >25

Exclusion criteria

Exclusion Criteria:

  • \<18 years old
  • Preoperative ARISCAT score estimation \<26
  • Women during pregnancy or just given birth
  • Other type of anesthesia (Not general)
  • of administration of neuromuscular blockade agents.
  • Contraindication of cease of spontaneous ventilation.
  • Mechanical ventilation without endotracheal intubation.
  • Severe heart failure / Severe cardiac arrhythmia.
  • Severe emphysematous lung disease.
  • Patient denial of participation in the trial.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
200 participants (estimated)

Study arms

  • Other
    Lung Protective Ventilation

    CONVENTIONAL LUNG PROTECTIVE VENTILATION This group is mechanically ventilated with Invasive Mechanical Ventilation with PEEP 8 cm H20 Tidal Volume (VT) 8 ml/kg Ideal Body Weight (IBW) Respiratory Rate (RR) --\> Arterial Partial CO2 Pressure (PaCO2) = 35-45 mmHg Inspired Oxygen Fracture (FiO2) 0.4 - 0.5 --\> Peripheral Oxygen Saturation (SpO2) \> 93% Recruitment Maneuver (as described) every hour

    Procedure: Lung Protective Ventilation

  • Active comparator
    Minimum Driving Pressure

    This group is mechanically ventilated with Invasive Mechanical Ventilation with PEEP; Initially 8 cm H2. Titrated at level with Minimum Driving Pressure after first recruitment - titration maneuver followed by new recruitment maneuver VT 8 ml/kg IBW RR --\> PaCO2 = 35-45 mmHg FiO2 0.4 - 0.5 --\> SpO2 \> 93% Recruitment Maneuver (as described) every hour

    Procedure: PEEP titration for Minimum Driving Pressure

Interventions

  • ProcedurePEEP titration for Minimum Driving Pressure

    This group is mechanically ventilated with Invasive Mechanical Ventilation with Volume Control Ventilation mode with PEEP Initially 8 cm H2O. Afterwards, the lungs are recruited with the aforementioned maneuver. During subsequent derecruitment, PEEP is decreased by 2 cm H20 and compliance is noted in each stage. The goal is to find PEEP with maximum compliance (Cmax). A new recruitment maneuver follows and during derecruitment PEEP is set at the optimum value that was previously defined. VT 8 ml/kg IBW RR --\> PaCO2 = 35-45 mmHg FiO2 0.4 - 0.5 --\> SpO2 \> 93% Recruitment Maneuver (as described) every hour

    Also known as: Maximum compliance mechanical ventilation, Cmax Mechanical Ventilation

  • ProcedureLung Protective Ventilation

    This group is mechanically ventilated with Invasive Mechanical Ventilation with Volume Control Ventilation mode with PEEP 8 cm H2O. VT 8 ml/kg IBW RR --\> PaCO2 = 35-45 mmHg FiO2 0.4 - 0.5 --\> SpO2 \> 93% Recruitment Maneuvers (as described) every hour

06

What researchers measure

Primary outcomes

  1. Postoperative Pulmonary Complications

    Number of the following Postoperative Pulmonary Complications 1. Postoperative Atelectasis (based on Chest X-Ray in Post-Anesthesia Care Unit - PACU) 2. Postoperative Respiratory Failure based on Arterial Blood Gases in PACU (type I and/or II) 3. Postoperative Bronchospasm 4. Postoperative Pleural Effusion 5. Postoperative Pneumonia 6. Postoperative Aspiration Pneumonitis 7. Postoperative Postoperative Pneumothorax

    Time frame: Atelectasis -> Within 1 hour in PACURespiratory failure -> Immediately postoperatively & after 30 minutes in PACU.Bronchospasm, Pleural Effusion, Pneumonia, Aspiration Pneumonitis, Pneumothorax -> from immediately postoperative until end of study

Secondary outcomes

  1. Hospital Stay

    Total hospital stay days from day of operation until hospital discharge.

    Time frame: From day of operation until the end of patient stay inside hospital, because of return to home or due to death.

  2. ICU need.

    Potential Need for ICU admission.

    Time frame: From day of operation until the end of patient stay inside hospital, because of return to home or due to death.

  3. ICU stay

    In case of ICU need, total days of ICU stay.

    Time frame: From day of operation until the end of patient stay inside hospital, because of return to home or due to death.

  4. 28 Day mortality

    Incidence of death in 28 days in each group.

    Time frame: From day of operation until up to 28 days.

  5. Mechanical Power (MP)

    To calculate MP, the following must be recorded: RR, Peak Airway Pressure (Ppeak), Plateau Pressure (Pplat), and PEEP. The simplified equation will be used; MP = 0.098 × RR × \[Ppeak - (Plat-PEEP)/2\]

    Time frame: From the moment of beginning of operation until the moment of the end of operation and mechanical ventilation

  6. Volume-normalized Mechanical Power (MPcrs)

    MPcrs = MP/Respiratory System Compliance (Crs)

    Time frame: From the moment of beginning of operation until the moment of the end of operation and mechanical ventilation

  7. Elastic Power (EP)

    To calculate EP, the following must be recorded: RR, VT, Pplat, and PEEP. The following equation will be used: EP = 0.098 × RR × VT × \[(Plat+PEEP)/2\]

    Time frame: From the moment of beginning of operation until the moment of the end of operation and mechanical ventilation

  8. Volume-normalized Elastic Power (EPcrs)

    EPcrs = EP/Crs

    Time frame: From the moment of beginning of operation until the moment of the end of operation and mechanical ventilation

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: Yes — Excel file per patient containing all the collected data Preoperatively; Patient demographics, ARISCAT score Perioperatively; Mechanical ventilation settings and measurements. Type and duration of operation. Anesthetic methods. Aerial blood gases results. Data from haemodynamic monitoring. Quantity of crystalloids , vasoperessors and inotropes. Postoperatively; Arterial blood gases results in PACU, Potential presence of other postoperative pulmonary complications. Statistic analysis of the collected data

Supporting information: Study protocol, Statistical analysis plan, Clinical study report

Time frame: Beginning at the end of data collection, possibly August 2027. Ending 3 years after publication of results.

Access criteria: Reviewers. Researchers of relevant subjects. Anesthesiologists with interest in optimum mechanical ventilation. A request via email will be initially needed. A data sharing agreement will be needed to be signed.

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 11, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07186933
Lead sponsor
University General Hospital of Patras
Responsible party
Antonios Kostouros (Prinsipal Investigator, Antonios Kostouros, University General Hospital of Patras) — Principal investigator
First posted
Sep 22, 2025
Start date
Nov 3, 2025
Primary completion
Aug 31, 2027 (estimated)
Completion
Nov 30, 2027 (estimated)
Last update
Feb 11, 2026

Study contacts

Antonios D Kostouros, Resident
Contact
kostouros.a@yahoo.com
+306975920528
Diamanto Aretha, A. Professor
study director · University of Patras
Antonios Kostouros, Resident
principal investigator · University of Patras

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion